glp-1 fitness news medications are reshaping the future of weight management, and the industry has a pivotal role to play. At the #HFAEuropeanCongress, we're bringing together leading experts to discuss how training and Rethinking Exercise on GLP-1 Medications:

The war is on between compounding pharmacies making knockoff versions of popular weight loss drugs and pharma giants Novo Nordisk and Eli Lilly, who want to protect their right to sell their patent | Novo Nordisk has asked the FDA to prevent compounders from manufacturing copycat versions of its juggernaut diabetes and obesity treatments Ozempic and Wegovy, claiming the drugs are too complex to safely replicate.

Possible contributing factors include: - Dry mouth - Enamel erosion - Gum inflammation - Changes in eating habits Regular dental checkups and preventive care play a key role in protecting your smile and addressing issues early

A Texas surgeon explains what it does, what it can't do and the permanent alternative.

The study demonstrates that quantitative target engagement of dual agonists can be assessed by PET.

Our Scientific Affairs team made the trip to New Orleans for the #ADASciSessions, where we presented new real-world GLP-1 research, including: Better Sleep, More Energy, and Less Daytime Sleepiness on Ro: evaluating sleep apnea outcomes among patients treated with tirzepatide on Ro